Legend Biotech (LEGN) Leases (2019 - 2025)

Legend Biotech has reported Leases for 7 years, with the latest figure at $285.2 million in Q4 2025.

• For the quarter ending Q4 2025, Leases rose 179.88% year-over-year to $285.2 million; the trailing twelve-month figure through Dec 2025 stood at $285.2 million (up 179.88% YoY), and the FY2025 full-year result was $285.2 million, up 179.88% from the prior year.
• Leases for Q4 2025 stood at $285.2 million, up from $142.3 million in the prior quarter.
• The five-year high for Leases was $285.2 million in Q4 2025, with the low at $7547.0 in Q1 2021.
• Historically, Leases has averaged $84.5 million across 5 years, with a median of $80.3 million in 2023.
• Annual changes were most pronounced in 2022 — Leases jumped 526877.61% — and 2024, when it decreased 0.35%.
• Legend Biotech's Leases stood at $38.3 million in 2021, then soared by 45.21% to $55.6 million in 2022, then jumped by 44.81% to $80.5 million in 2023, then climbed by 26.58% to $101.9 million in 2024, then jumped by 179.88% to $285.2 million in 2025.
• The last three Leases figures came in at $285.2 million (Q4 2025), $142.3 million (Q3 2025), and $127.2 million (Q2 2025), per Business Quant data.